Pharmteco
Scope
Date
~
-
Bio & Pharma
SK Pharmteco launches new viral vector platforms, key for CGT
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has recently introduced two...
Nov 22, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco gears up for big leap in advanced biotherapies
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is upping the ante in its b...
Aug 17, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco secures 12 global pharma clients, sets up US R&D center
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has secured 12 global pharm...
Aug 09, 2023 (Gmt+09:00)
-
Pre-IPOs
SK Pharmteco to raise $500 mn in pre-IPO, aims for 2025 listing
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is set to raise $500 millio...
Jul 18, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco opens 2nd biomanufacturing plant in France
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has secured a second plant ...
Jun 23, 2023 (Gmt+09:00)
-
Pre-IPOs
SK Pharmteco again seeks $382 mn in pre-IPO funding
SK Pharmteco Co., a contract development and manufacturing organization (CDMO), is eyeing pre-initial public offering funding again after it dropped...
Mar 21, 2023 (Gmt+09:00)
-
Pre-IPOs
SK Pharmteco to raise up to $498 mn on $5 bn valuation
SK Pharmteco, a contract development and manufacturing organization (CDMO) for pharmaceuticals, is slated to raise 400 billion ($332.2 million) to 6...
Jan 10, 2022 (Gmt+09:00)